Search

Abbott Laboratories

Chiusa

SettoreSettore sanitario

104.87 1.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

102.95

Massimo

105.19

Metriche Chiave

By Trading Economics

Entrata

-149M

928M

Vendite

1.4B

13B

P/E

Media del settore

33.786

49.241

EPS

1.31

Rendimento da dividendi

2.36

Margine di Profitto

7.369

Dipendenti

122,000

EBITDA

548M

2.8B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+17.76% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

2.36%

2.15%

Utili prossimi

21 gen 2027

Prossima data del Dividendo

16 nov 2026

Prossima data del' Ex Dividendo

14 gen 2027

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

16B

180B

Apertura precedente

103.46

Chiusura precedente

104.87

Abbott Laboratories Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 ott 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

22 ott 2026, 23:51 UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

21 ott 2026, 23:06 UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

20 ott 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

19 ott 2026, 23:41 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

17 ott 2026, 00:01 UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

16 ott 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

15 ott 2026, 23:06 UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

14 ott 2026, 23:31 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

13 ott 2026, 20:08 UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

12 ott 2026, 23:06 UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

10 ott 2026, 00:01 UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

9 ott 2026, 22:01 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

8 ott 2026, 22:45 UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

7 ott 2026, 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

6 ott 2026, 20:07 UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

5 ott 2026, 23:05 UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2 ott 2026, 20:07 UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

1 ott 2026, 20:07 UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

30 set 2026, 20:07 UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

29 set 2026, 23:00 UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

25 set 2026, 20:07 UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

24 set 2026, 19:51 UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

23 set 2026, 20:01 UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

22 set 2026, 23:41 UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

21 set 2026, 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

16 set 2026, 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

15 set 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

14 set 2026, 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

12 set 2026, 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

Confronto tra pari

Modifica del prezzo

Abbott Laboratories Previsione

Obiettivo di Prezzo

By TipRanks

17.76% in crescita

Previsioni per 12 mesi

Media 122.118 USD  17.76%

Alto 135 USD

Basso 115 USD

Basato su 19 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Abbott Laboratories - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

19 ratings

18

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat